(KSS) Kohl's - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5002551043
Stock: Apparel, Footwear, Accessories, Home Goods, Beauty
Total Rating 35
Risk 65
Buy Signal -1.17
| Risk 5d forecast | |
|---|---|
| Volatility | 67.9% |
| Relative Tail Risk | -16.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 3.71 |
| Character TTM | |
|---|---|
| Beta | 2.454 |
| Beta Downside | 2.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.01% |
| CAGR/Max DD | -0.11 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: KSS Kohl's March 04, 2026
Kohls Corporation (KSS) is a U.S. omnichannel retailer. The company sells apparel, footwear, accessories, beauty items, and home goods through both physical stores and its e-commerce platform.
Kohls offers products under proprietary brands like Apt. 9 and Sonoma Goods for Life, alongside licensed brands such as LC Lauren Conrad. The retail sector is characterized by intense competition and evolving consumer preferences, requiring companies to adapt their product offerings and sales channels.
Understanding a companys brand portfolio and distribution strategy is crucial for evaluating its market position. For further insights into KSSs financial performance and market data, consider exploring ValueRay.
Headlines to watch out for
- Consumer discretionary spending impacts apparel and home goods sales
- Inventory management affects profitability and markdown frequency
- E-commerce growth competes with brick-and-mortar store traffic
- Private label brand performance influences gross margins
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 194.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.60 > 1.0 |
| NWC/Revenue: 6.36% < 20% (prev 1.33%; Δ 5.02% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.23b > Net Income 194.0m |
| Net Debt (6.66b) to EBITDA (1.25b): 5.34 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.0m) vs 12m ago 2.68% < -2% |
| Gross Margin: 35.97% > 18% (prev 0.36%; Δ 3561 % > 0.5%) |
| Asset Turnover: 107.9% > 50% (prev 111.5%; Δ -3.57% > 0%) |
| Interest Coverage Ratio: 1.78 > 6 (EBITDA TTM 1.25b / Interest Expense TTM 303.0m) |
Altman Z'' 1.08
| A: 0.07 (Total Current Assets 4.31b - Total Current Liabilities 3.31b) / Total Assets 14.14b |
| B: 0.08 (Retained Earnings 1.11b / Total Assets 14.14b) |
| C: 0.04 (EBIT TTM 538.0m / Avg Total Assets 14.60b) |
| D: 0.11 (Book Value of Equity 1.11b / Total Liabilities 10.21b) |
| Altman-Z'' Score: 1.08 = BB |
Beneish M -3.12
| DSRI: 1.01 (Receivables 159.0m/167.0m, Revenue 15.75b/16.78b) |
| GMI: 0.99 (GM 35.97% / 35.67%) |
| AQI: 1.04 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 0.94 (Revenue 15.75b / 16.78b) |
| TATA: -0.07 (NI 194.0m - CFO 1.23b) / TA 14.14b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of KSS shares?
As of March 09, 2026, the stock is trading at USD 15.12 with a total of 5,238,530 shares traded.
Over the past week, the price has changed by -2.33%, over one month by -13.85%, over three months by -33.03% and over the past year by +30.73%.
Over the past week, the price has changed by -2.33%, over one month by -13.85%, over three months by -33.03% and over the past year by +30.73%.
Is KSS a buy, sell or hold?
Kohl's has received a consensus analysts rating of 2.50.
Therefor, it is recommend to sell KSS.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 6
- StrongSell: 2
What are the forecasts/targets for the KSS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.5 | 42.2% |
| Analysts Target Price | 21.5 | 42.2% |
KSS Fundamental Data Overview March 08, 2026
P/E Trailing = 8.7399
P/E Forward = 14.771
P/S = 0.1077
P/B = 0.4365
P/EG = 0.8814
Revenue TTM = 15.75b USD
EBIT TTM = 538.0m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 225.0m USD (from shortTermDebt, last quarter)
Debt = 6.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.66b USD (from netDebt column, last quarter)
Enterprise Value = 8.35b USD (1.70b + Debt 6.80b - CCE 144.0m)
Interest Coverage Ratio = 1.78 (Ebit TTM 538.0m / Interest Expense TTM 303.0m)
EV/FCF = 8.20x (Enterprise Value 8.35b / FCF TTM 1.02b)
FCF Yield = 12.20% (FCF TTM 1.02b / Enterprise Value 8.35b)
FCF Margin = 6.47% (FCF TTM 1.02b / Revenue TTM 15.75b)
Net Margin = 1.23% (Net Income TTM 194.0m / Revenue TTM 15.75b)
Gross Margin = 35.97% ((Revenue TTM 15.75b - Cost of Revenue TTM 10.09b) / Revenue TTM)
Gross Margin QoQ = 37.48% (prev 38.35%)
Tobins Q-Ratio = 0.59 (Enterprise Value 8.35b / Total Assets 14.14b)
Interest Expense / Debt = 1.10% (Interest Expense 75.0m / Debt 6.80b)
Taxrate = 4.39% (5.00m / 114.0m)
NOPAT = 514.4m (EBIT 538.0m * (1 - 4.39%))
Current Ratio = 1.30 (Total Current Assets 4.31b / Total Current Liabilities 3.31b)
Debt / Equity = 1.73 (Debt 6.80b / totalStockholderEquity, last quarter 3.93b)
Debt / EBITDA = 5.34 (Net Debt 6.66b / EBITDA 1.25b)
Debt / FCF = 6.53 (Net Debt 6.66b / FCF TTM 1.02b)
Total Stockholder Equity = 3.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 194.0m / Total Assets 14.14b)
RoE = 5.03% (Net Income TTM 194.0m / Total Stockholder Equity 3.86b)
RoCE = 10.00% (EBIT 538.0m / Capital Employed (Equity 3.86b + L.T.Debt 1.52b))
RoIC = 9.15% (NOPAT 514.4m / Invested Capital 5.62b)
WACC = 3.83% (E(1.70b)/V(8.50b) * Re(14.96%) + D(6.80b)/V(8.50b) * Rd(1.10%) * (1-Tc(0.04)))
Discount Rate = 14.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.79%
[DCF] Terminal Value 80.82% ; FCFF base≈768.2m ; Y1≈504.3m ; Y5≈230.1m
[DCF] Fair Price = 6.00 (EV 7.33b - Net Debt 6.66b = Equity 673.2m / Shares 112.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.68 | EPS CAGR: -1.13% | SUE: -1.87 | # QB: 0
Revenue Correlation: -41.60 | Revenue CAGR: -14.73% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=-0.20 | Chg7d=+0.002 | Chg30d=+0.013 | Revisions Net=+2 | Analysts=10
EPS next Year (2027-01-31): EPS=1.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-34.3% | Growth Revenue=-0.8%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 15.0% - Earnings Yield 11.4%)
[Growth] Growth Spread = -3.2% (Analyst 0.4% - Implied 3.5%)
P/E Forward = 14.771
P/S = 0.1077
P/B = 0.4365
P/EG = 0.8814
Revenue TTM = 15.75b USD
EBIT TTM = 538.0m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 225.0m USD (from shortTermDebt, last quarter)
Debt = 6.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.66b USD (from netDebt column, last quarter)
Enterprise Value = 8.35b USD (1.70b + Debt 6.80b - CCE 144.0m)
Interest Coverage Ratio = 1.78 (Ebit TTM 538.0m / Interest Expense TTM 303.0m)
EV/FCF = 8.20x (Enterprise Value 8.35b / FCF TTM 1.02b)
FCF Yield = 12.20% (FCF TTM 1.02b / Enterprise Value 8.35b)
FCF Margin = 6.47% (FCF TTM 1.02b / Revenue TTM 15.75b)
Net Margin = 1.23% (Net Income TTM 194.0m / Revenue TTM 15.75b)
Gross Margin = 35.97% ((Revenue TTM 15.75b - Cost of Revenue TTM 10.09b) / Revenue TTM)
Gross Margin QoQ = 37.48% (prev 38.35%)
Tobins Q-Ratio = 0.59 (Enterprise Value 8.35b / Total Assets 14.14b)
Interest Expense / Debt = 1.10% (Interest Expense 75.0m / Debt 6.80b)
Taxrate = 4.39% (5.00m / 114.0m)
NOPAT = 514.4m (EBIT 538.0m * (1 - 4.39%))
Current Ratio = 1.30 (Total Current Assets 4.31b / Total Current Liabilities 3.31b)
Debt / Equity = 1.73 (Debt 6.80b / totalStockholderEquity, last quarter 3.93b)
Debt / EBITDA = 5.34 (Net Debt 6.66b / EBITDA 1.25b)
Debt / FCF = 6.53 (Net Debt 6.66b / FCF TTM 1.02b)
Total Stockholder Equity = 3.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 194.0m / Total Assets 14.14b)
RoE = 5.03% (Net Income TTM 194.0m / Total Stockholder Equity 3.86b)
RoCE = 10.00% (EBIT 538.0m / Capital Employed (Equity 3.86b + L.T.Debt 1.52b))
RoIC = 9.15% (NOPAT 514.4m / Invested Capital 5.62b)
WACC = 3.83% (E(1.70b)/V(8.50b) * Re(14.96%) + D(6.80b)/V(8.50b) * Rd(1.10%) * (1-Tc(0.04)))
Discount Rate = 14.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.79%
[DCF] Terminal Value 80.82% ; FCFF base≈768.2m ; Y1≈504.3m ; Y5≈230.1m
[DCF] Fair Price = 6.00 (EV 7.33b - Net Debt 6.66b = Equity 673.2m / Shares 112.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.68 | EPS CAGR: -1.13% | SUE: -1.87 | # QB: 0
Revenue Correlation: -41.60 | Revenue CAGR: -14.73% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=-0.20 | Chg7d=+0.002 | Chg30d=+0.013 | Revisions Net=+2 | Analysts=10
EPS next Year (2027-01-31): EPS=1.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-34.3% | Growth Revenue=-0.8%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 15.0% - Earnings Yield 11.4%)
[Growth] Growth Spread = -3.2% (Analyst 0.4% - Implied 3.5%)